R
4.91
0.37 (8.15%)
| Previous Close | 4.54 |
| Open | 4.48 |
| Volume | 53,842 |
| Avg. Volume (3M) | 692,006 |
| Market Cap | 3,624,940 |
| Price / Earnings (TTM) | 0.019 |
| Price / Sales | 0.290 |
| Price / Book | 30.42 |
| 52 Weeks Range | |
| Earnings Date | 14 Aug 2025 |
| Profit Margin | -48.26% |
| Operating Margin (TTM) | -165.23% |
| Diluted EPS (TTM) | 264.12 |
| Quarterly Revenue Growth (YOY) | -42.70% |
| Total Debt/Equity (MRQ) | 10.57% |
| Current Ratio (MRQ) | 1.53 |
| Operating Cash Flow (TTM) | -4.47 M |
| Levered Free Cash Flow (TTM) | -1.48 M |
| Return on Assets (TTM) | -53.50% |
| Return on Equity (TTM) | -120.16% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | ReShape Lifesciences, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Relative Valuation | NA |
| Financial Health | -1.2 |
| Macro Environment | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | -0.35 |
Select this tab to load the latest available analysis.
|
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 10.63% |
| % Held by Institutions | 0.73% |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |